R. Scott Struthers
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Start not stated–2026-09-01
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Crinetics Pharmaceuticals, Inc. (CRNX) | President and Chief Executive Officer | $718,500 | $11,628,959 |
| 2024 | Crinetics Pharmaceuticals, Inc. (CRNX) | President and Chief Executive Officer | $653,833 | $10,533,579 |
| 2023 | Crinetics Pharmaceuticals, Inc. (CRNX) | President and Chief Executive Officer | $614,000 | $5,747,994 |
| 2021 | Crinetics Pharmaceuticals, Inc. (CRNX) | President and Chief Executive Officer | $567,000 | $4,144,049 |
| 2020 | Crinetics Pharmaceuticals, Inc. (CRNX) | President and Chief Executive Officer | $543,550 | $3,826,332 |
| 2019 | Crinetics Pharmaceuticals, Inc. (CRNX) | President and Chief Executive Officer | $541,708 | $3,766,662 |
| 2018 | Crinetics Pharmaceuticals, Inc. (CRNX) | — | $409,913 | $3,041,435 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.